24-25 February Siena, Italy
|
|
- Scarlett Fletcher
- 6 years ago
- Views:
Transcription
1 WORKSHOP FINAL PROGRAMME AND ABSTRACT BOOK Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis February Siena, Italy
2
3 Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis Overview MR imaging has dramatically improved the accuracy in the diagnosis and in the quantification of tissue damage in multiple sclerosis (MS). Today it is the most important paraclinical tool for the monitoring of treatment efficacy and safety, both in clinical practice and clinical trials settings. Advanced MRI has speeded up the discovery of new pathogenetic mechanisms and functional consequences of MS. Aim of this workshop is to comprehensively summarize the main applications of MRI to MS field from diagnosis to treatment monitoring. The use of MRI markers as endpoint in clinical trials will be also discussed. An overview of the main software packages suitable to assess lesions and atrophy in brain and spinal cord will be illustrated. Learning objectives By attending this workshop, participants will be able to: Illustrate and apply MRI diagnostic criteria Explain the key elements of differential diagnosis on MRI Describe basic principles and application of quantitative MRI Target audience Neurologists treating patients with MS and with a interest in MRI. Chairs Nicola De Stefano Department of Neurological and Behavioural Sciences University of Siena Siena, Italy Claudio Gasperini Department of Neurosciences Hospital S. Camillo Forlanini Rome, Italy 1
4 CME Provider EXCEMED is a non profit foundation dedicated, since the last four decades, to the development of high-quality medical education programme all over the world. EXCEMED adheres to the guidelines and standards of the European Accreditation Council for Continuing Medical Education (EACCME ) which states that continuing medical education must be balanced, independent, objective, and scientifically rigorous. Continuing medical education EXCEMED ( is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), The CME workshop Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis held on February 2016 in Siena, Italy, is designated for a maximum of 8 (eight) hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME credits are recognized by the American Medical Association (AMA) towards the Physician's Recognition Award (PRA). To convert EACCME credit to AMA PRA category 1 credit, please contact the AMA. EXCEMED adheres to the principles of the Good CME Practice group (gcmep). 2
5 Faculty Marco Battaglini Department of Neurological and Behavioural Sciences University of Siena Siena, Italy Nicola De Stefano Department of Neurological and Behavioural Sciences University of Siena Siena, Italy Claudio Gasperini Department of Neurosciences Hospital S. Camillo Forlanini Rome, Italy Antonio Giorgio Department of Neurological and Behavioural Sciences University of Siena Siena, Italy Carla Tortorella Department of Medical Basic Sciences, Neurosciences and Sense Organs University of Bari Bari, Italy 3
6 Programme
7 Wednesday, 24 February 2016 Thursday, 25 February Opening and welcome N. De Stefano (Italy) L1: How to use MRI for diagnosing MS: past, current and future diagnostic criteria C. Gasperini (Italy) L2: What are we looking at: sensitivity and specificity of MRI N. De Stefano (Italy) L3: What we should pay attention for: key elements for an MRI differential diagnosis N. De Stefano (Italy) Coffee break L4: MRI to assess prognosis C. Gasperini (Italy) L5: MRI to assess treatment response C. Gasperini (Italy) L6: MRI to assess safety during treatment N. De Stefano (Italy) L7: MRI as suitable endpoint in clinical trials: state of the art and future proposals C. Gasperini (Italy) L8: Brain function beyond structure: the role of advanced imaging A. Giorgio (Italy) L9: Future MRI markers in MS N. De Stefano (Italy) Coffee break L10: Real assessments of MRI lesions and Atrophy: the post-processing landscape M. Battaglini (Italy) Visit to the MRI Unit A. Giorgio and M. Battaglini (Italy) Final discussion and wrap-up Concluding lunch and participants departure General discussion Lunch Clinical cases session C. Tortorella (Italy) Round up End of the first day Legend: L : Lecture; : Discussion; : Clinical cases 5
8 General information Language The official language of this workshop is English. CME Provider EXCEMED - Excellence in Medical Education Programme and Relations Manager: Serena Dell'Ariccia T F serena.dellariccia@excemed.org Medical Advisor: Doriana Landi doriana.landi@gmail.com For any logistic information please contact: Meridiano Congress International Congress Manager: Denise Latino T F denise.latino@meridiano.it 6
9 Disclosure of faculty relationships EXCEMED adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME ) and all other professional organizations, as applicable, which state that programmes awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the programme (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so that participants may form their own judgements, based on full disclosure of the facts. Further, all opinions and recommendations presented during the programme and all programme-related materials neither imply an endorsement nor a recommendation on the part of EXCEMED. All presentations represent solely the independent views of the presenters/authors. The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non-emea/fda approved (off-label) uses of drugs: Marco Battaglini Declared no potential conflict of interest. Nicola De Stefano Declared the receipt of honoraria and consultation fees from Novartis, Merck Serono, Biogen and Roche. He declared to be member of Novartis, Merck Serono, Biogen and Roche advisory boards, board of directors or other similar groups and the participation to speakers bureau sponsored by Novartis, Merck Serono and Genzyme.. Claudio Gasperini Declared the receipt of grants and contracts from Teva. He declared the receipt of honoraria and consultation fees from Teva, Biogen Merck Serono and Bayer. Antonio Giorgio Declared no potential conflict of interest.. Carla Tortorella Declared the receipt of Honoraria and consultation fees from Merck Serono, Biogen, Teva, Shering and Genzyme. She declared to be member of Merck Serono, Biogen, Teva and Shering advisory boards, board of directors or other similar groups.. 7
10 Abstracts
11 L1. How to use MRI for diagnosing MS: past, current and future diagnostic criteria Claudio Gasperini Department of Neurosciences, Hospital S. Camillo Forlanini, Rome, Italy Magnetic resonance imaging (MRI) has been formally included in the diagnostic work-up of patients presenting with a clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS) in 2001 by a Panel of International (IP) experts. MS diagnosis requires the demonstration of disease dissemination in space (DIS) and time (DIT) and the exclusion of other conditions that can mimic MS by their clinical and laboratory profile. MRI can support and substitute clinical information for the diagnosis of MS allowing an earlier and accurate diagnosis and, as a consequence, earlier treatment. MRI criteria for MS are based on features of focal lesions in the white matter (WM) of the central nervous system (CNS) that are considered typical for this condition in terms of distribution, morphology, evolution and signal abnormalities on conventional MRI sequences. Based on available literature from research studies, several modifications of MRI diagnostic criteria have been proposed over the course of years, which were mainly based on simplification of lesion count models for demonstrating DIS, timing of acquisition of MRI scans for demonstrating DIT, and weighting the value of spinal cord imaging. This evidence has been reviewed in 2007 by the European multicenter collaborative research network that studies MRI in MS (MAGNIMS) leading to a proposal for new MRI criteria to be applied in MS. These MAGNIMS criteria are currently included in the most recent revision of the IP criteria. New data regarding the application of MRI for demonstrating DIS and DIT have become available and a new proposal to modify the diagnostic work-up will be presented. 9
12 L2. What are we looking at: sensitivity and specificity of MRI Nicola De Stefano Department of Neurological and Behavioural Sciences, University of Siena, Siena, Italy Conventional and non-conventional MR techniques have demonstrated to provide structural, biochemical, and functional indices able to give accurate information on the status of CNS system. This quantitative MR metrics allow accurate cross-sectional and longitudinal measurements of different brain structures and their use in multiple sclerosis (MS) has facilitated the diagnosis of the disease and has enhanced greatly our understanding of the pathophysiology of this disorder, providing better specificity and sensitivity than clinical measures. We will focus on recent data that have used quantification of focal demyelinating lesions and diffuse tissue damage, discussing advances and limitations of a modern use of MRI in the management of MS patients. 10
13 L3. What we should pay attention for: key elements for an MRI differential diagnosi Nicola De Stefano Department of Neurological and Behavioural Sciences, University of Siena, Siena, Italy Conventional MRI is crucial for an early diagnosis of MS, which allows an early treatment. However, the exclusion of other neurological disorders before making the definite diagnosis of MS is also essential. The limited specificity of abnormalities disclosed by MRI may increase the likelihood of diagnosis of multiple sclerosis in patients affected by other disorders. The available criteria for diagnosis of MS must take advantage of the potential of MRI to detect features not suggestive of MS. Recognition of such features in the work-up of patients suspected of having MS may reduce the likelihood of a false positive diagnosis. We will discuss these potential red flags and how they should be used in the setting of clinically suspected MS. 11
14 L4. MRI to assess prognosis Claudio Gasperini Department of Neurosciences, Hospital S. Camillo Forlanini, Rome, Italy The utility of magnetic resonance imaging (MRI) in predicting the occurrence of a second neurologic episode and, therefore, conversion to clinically definite MS in patients with a first demyelinating event, is well established. The place and contribution of imaging in evaluating the long-term prognosis is less obvious, as illustrated in a prospective cohort study of 140 patients with a first neurologic episode suggestive of MS. Untreated patients reevaluated after a mean follow- up of 20 years, brain T2 lesion volume at all time points, namely, baseline and 5, 10, 14, and 20 years, correlated moderately with EDSS at the end of follow-up. Similar conclusions were reached when analysis was restricted to the subgroup of patients with clinically definite MS. The change in T2 lesion volume on brain MRI over the first 5 years of the disease also correlated with concurrent change in EDSS and weakened thereafter. While patients with a higher number of T2 lesions at baseline on brain imaging were more likely to be disabled 20 years later, about one-third of patients with more than 10 T2 lesions at baseline had minimal disability at the end of follow- up. The potential role of brain and spinal cord atrophy such as the unconventional MRI sequences will be discussed. 12
15 L5. MRI to assess treatment response Claudio Gasperini Department of Neurosciences, Hospital S. Camillo Forlanini, Rome, Italy Several new drugs have recently been approved for the treatment of multiple sclerosis (MS), creating an imperative for clinicians to make prompt treatment decisions for patients with suboptimal treatment response. This is difficult due to the inherent uncertainties in defining response or non-response to therapy in a chronic inflammatory and demyelinating disease such as MS, but it is certainly complicated by the lack of a standardized definition of the clinical outcomes used to assess improvement of worsening of the disease recently. Many studies have evaluated the role of clinical (i.e. relapses and disability progression) and magnetic resonance imaging (MRI) markers (i.e., white matter lesions) to define responder or non-responders to Interferon (IFN), reporting conflicting results., due to the large heterogeneity in both measured markers and outcome assessments. This heterogeneity precludes a valuable comparison of the different markers and scores of response across different studies. We will provide new insight into the role of markers of response to MS therapy, focusing on MRI lesions (alone or in combination with clinical variables). 13
16 L6. MRI to assess safety during treatment Nicola De Stefano Department of Neurological and Behavioural Sciences, University of Siena, Siena, Italy The use of magnetic resonance imaging (MRI) techniques has provided specific information on the heterogeneous pathologic substrate of MS lesions, offering the ability to observe and quantify the evolution of lesions and normal-appearing brain tissue. Moreover, the process of identifying effective therapies for MS patients has been aided by the use of serial MRI to sensitively detect sub-clinical disease modifying treatment effects at an earlier stage than is possible using clinical disease activity measures. Against this background, the major contribution of MRI to monitoring safety during specific MS treatments for a better management of the single MS patient will be discussed. 14
17 Clinical cases session Carla Tortorella Department of Medical Basic Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy The main objective of the clinical case session will be to summarize the core applications of MRI to the MS field from diagnosis to treatment monitoring in clinical practice. In this practical session, participants will learn to recognize MS from MS disease mimicking, gathering clinical and MRI data. Furthermore, the role of MRI in monitoring MS therapy and identifying treatment-relatedside effects will be discussed. Several case studies and patient experiences will be illustrated, drawing attention to the role of MRI in: 1. Preclinical diagnosis and radiologically isolated syndromes (RIS). 2. Differential diagnosis (MS vs neuromyelitis optica spectrm disorders-nmosd, acute disseminated encephalomyelitis ADEM, other autoimmune vasculitis). 3. Treatment monitoring and safety issues connected to treatment-related adverse events (progressive multifocal leukoencephalopathy -PML). Interaction will be encouraged by using MRI scans and photography. 15
18 L7. MRI as suitable endpoint in clinical trials: state of the art and future proposals Claudio Gasperini Department of Neurosciences, Hospital S. Camillo Forlanini, Rome, Italy MRI is used both in the diagnosis of Multiple Sclerosis (MS) and in monitoring disease activity in patients with established MS. The MRI can show the development of new damage as it occurs over time. T2-weighted and gadolinium enhanced T1-weighted MRI scans measure plaque burden and breakdown of the blood-brain barrier, respectively, in MS lesions. Using Conventional MRI data, it is possible according the new Mc Donald Criteria, satisfy the dissemination in space and time since the first episode simplifying the diagnostic process with fewer required MRI examinations. This allow more rapid diagnosis of MS preserving equivalent specificity and/or sensitivity in comparison with past criteria. Moreover, the evaluation of MRI activity is widely used outcome measures for monitoring disease activity in clinical trials and clinical practice. Several studies shows that MRI parameters: - Reflects early step in lesion development. - It is 5/10 times more sensitive than clinical relapses. - Shows moderate cross sectional relationship with relapse and disability. - Shows moderate predictive value for relapse in patients with early disease. - Shows concordance of effect of treatment on clinical and MRI outcome moderate to good especially in studies examined with effect in individual patients. - Shows good predictive value for treatment response. MRI it is a good surrogate marker in monitoring disease activity both in clinical trials and clinical practice. 16
19 L8. Brain function beyond structure: the role of advanced imaging Antonio Giorgio Department of Neurological and Behavioural Sciences, University of Siena, Siena, Italy Conventional MRI of the central nervous system is crucial for an early diagnosis and reliable monitoring of patients with multiple sclerosis (MS). Focal white matter (WM) lesions, as detected by MRI, are the pathologic hallmark of the disease and show some relationship with clinical disability, especially in the long term. Grey matter (GM) involvement occurs from disease onset in the form of focal (i.e., cortical lesions) and diffuse (i.e., atrophy) pathology. Both of them accrue over time and show close relationship with physical disability and cognitive impairment. The application of advanced quantitative MRI techniques such as magnetization transfer imaging (MTI), diffusion tensor imaging (DTI), proton MR spectroscopy (1H-MRS) and iron imaging has allowed to demonstrate since early stages of disease the presence of subtle and widespread MS pathology outside focal WM lesions in the so called normal appearing brain. In addition, studies using functional MRI have demonstrated that brain plasticity is driven by MS pathology, playing adaptive or maladaptive role towards clinical status of patients and explaining, at least in part, the clinicoradiological paradox of MS. 17
20 L9. Future MRI markers in MS Nicola De Stefano Department of Neurological and Behavioural Sciences, University of Siena, Siena, Italy Several modern MR techniques have been developed and applied during the last couple of decades, providing a number of imaging biomarkers that, complemented with conventional MRI measures, are able to better capture the complexity of the pathological process occurring in the MS brain. They have provided specific information on the heterogeneous pathologic substrate of MS lesions, offering the ability to observe and quantify the evolution of lesions and normal-appearing brain tissue. Moreover, the process of identifying effective therapies for MS patients has been aided by the use of serial MRI to sensitively detect sub-clinical disease modifying treatment effects at an earlier stage than is possible using clinical disease activity measures. Despite this, however, the role of MRI as surrogate for clinical endpoints is still controversial. Against this background, the MRI markers that could best contribute in the future to the understanding of the disease progression and the management of the single MS patient will be discussed. 18
21 L10. Real assessments of MRI lesions and Atrophy: the post-processing landscape Marco Battaglini Department of Neurological and Behavioural Sciences, University of Siena, Siena, Italy During this lesson, various methods for assessing brain atrophy and the volume and number of lesions will be briefly described, both in the cross-sectional and longitudinal settings. In particular, the differences between segmentation and registration methods for calculating atrophy will be discussed in detail and examples of software for each of these categories will be provided. Therefore, a pipeline for measuring brain volumes at a single point in time will be shown -- including the new lesion filling algorithms and new methods of assessing deep grey matter (GM) volumes. This pipeline will be explained by using the SIENAX algorithm. The next step will be to use the SIENA algorithm as an example of a similar pipeline for longitudinal changes in volumes. Finally, the problem of lesion segmentation will be addressed. Pros and cons of automated and semi-automated softwares will be reviewed, with particular attention to two main questions: i) how to create an effective gold standard for software validation and ii) when to use supervised methods and unsupervised methods. The lesson will end with the description of new software for calculating changes in volume and number of lesions. 19
22 NOTES
23 NOTES
24 NOTES
25 NOTES
26 All EXCEMED programmes are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products. These views are the responsibility of the named speakers, and do not represent an endorsement or recommendation on the part of EXCEMED. This programme is made possible thanks to an educational grant received from Merck KGaA, Darmstadt, Germany
27
28 Improving the patient's life through medical education EXCEMED - Excellence in Medical Education Headquarters 14, Rue du Rhône Geneva, Switzerland Representative Office Salita di San Nicola da Tolentino 1/b Rome, Italy T F Copyright EXCEMED, All rights reserved.
6-8 July Naples, Italy
PRACTICE TEACHING COURSE SCIENTIFIC PROGRAMME Metastatic colorectal cancer: from disease biology to clinical management 6-8 July 2016 - Naples, Italy Metastatic colorectal cancer: from disease biology
More informationTarget audience. Chair. Xxx Xxx
EXCEMED WORKSHOP The immunomodulatory role of therapeutic plasma exchange in neuromuscular and PNS diseases: a practical approach & new knowledge London, UK - 19 May 2018 The immunomodulatory role of therapeutic
More information9-10 November Nice, France
PRACTICE TEACHING COURSE SCIENTIFIC PROGRAMME Practice teaching course in head and neck cancer: focus on comprehensive management 9-10 November 2016 - Practice teaching course in head and neck cancer:
More information7 November Buenos Aires, Argentina
REGIONAL CONFERENCE FINAL PROGRAMME The Expert's view on growth hormone disorders 7 November 2016 - The Expert's view on growth hormone disorders Overview Growth hormone (GH) disorders are a wide range
More informationTarget audience. Chair. Xxx Xxx
STUDENTS FOR FREE EXCEMED WORKSHOP The immunomodulatory role of therapeutic plasma exchange in neuromuscular and PNS diseases: a practical approach & new knowledge London, UK - 19 May 2018 The immunomodulatory
More information2-4 November Rome, Italy
SCIENTIFIC PROGRAMME Shadow course: Following IVF experts in a clinical setting 2-4 November 2015 - Rome, Italy General information Venue This live educational course takes place at: G.EN.E.R.A. Center
More informationFondazione IRCCS, Istituto Nazionale dei Tumori. 2-4 March Milan, Italy
PRACTICE TEACHING COURSE PRELIMINARY PROGRAMME Practice teaching course in head and neck cancer, 2-4 March 2016 - Overview Head and neck cancer treatment requires multidisciplinary cooperation between
More information23-24 January Hamburg, Germany
PRELIMINARY PROGRAMME IVF Preceptorship Hamburg 23-24 January 2015 - Hamburg, Germany Dear participant, A warm welcome to all attending the IVF Preceptorship Hamburg. We would like to inform you that as
More informationPreceptorship course in metastatic colorectal cancer management
SCIENTIFIC PROGRAMME Preceptorship course in metastatic colorectal cancer management, Centre Hépato-Biliaire General information Live educational preceptorship course dates The live educational preceptorship
More informationThis live educational workshop is endorsed by MENACtrims (Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis).
EXCEMED Blended Education Back to the future: redefining the clinical course of multiple sclerosis Live intervention in Dubai, UAE - Pre-MENACTRIMS PRELIMINARY PROGRAMME Back to the future: redefining
More informationA CME-certified programme
Preliminary programme Residential course on rehabilitation in multiple sclerosis Valens, Switzerland 6-7 October 2016 A CME-certified programme OVERVIEW This residential course is designed for neurologists,
More information13-14 October Athens, Greece
INTERNATIONAL WORKSHOP FIRST SCIENTIFIC ANNOUNCEMENT From poor response to low prognosis concept: The new POSEIDON criteria 13-14 October 2017 - Athens, Greece From poor response to low prognosis concept:
More informationPRELIMINARY PROGRAMME H&N Preceptorship: focus on comprehensive management Nice, France
PRELIMINARY PROGRAMME H&N Preceptorship: focus on comprehensive management Live educational course dates The live educational course H&N Preceptorship: Focus on comprehensive management" will be held on
More informationTarget audience. Jorge Correale Department of Neurology Raúl Carrea Institute for Neurological Research (FLENI) Buenos Aires, Argentina
EXCEMED Blended Education Immune and clinical profiling in multiple sclerosis: laying groundwork for advanced approaches to treatment Live intervention in PRELIMINARY PROGRAMME Immune and clinical profiling
More information6-7 October 2016 Valens, Switzerland
PRACTICE TEACHING COURSE PRELIMINARY PROGRAMME Residential course on rehabilitation in multiple sclerosis 6-7 October 2016 Residential course on rehabilitation in multiple sclerosis Overview This residential
More informationJune Maharashtra, India
SCIENTIFIC PROGRAMME 2015 India CME Tour Clinical Chronic Diseases Management - Diabetes June 2015 - Maharashtra, India 2015 India CME Tour Clinical Chronic Diseases Management - Diabetes Aim Diabetes
More information5-6 June University of Pisa, Italy
SCIENTIFIC PROGRAMME International School of Thyroid Ultrasonography 5-6 June 2015 - University of Pisa, Italy General information Venue This live educational course takes place at the: University of
More informationTarget audience. Chair. Robert Fischer Fertility Centre Hamburg Hamburg, Germany
EXCEMED Blended Education Ovarian stimulation strategies: maximizing efficiency in ART Live intervention in Rio de Janeiro, Brazil PRELIMINARY PROGRAMME Ovarian stimulation strategies: maximizing efficiency
More informationUniversity of Pisa, Italy
SCIENTIFIC PROGRAMME International School of Thyroid Ultrasonography University of Pisa, Italy Live educational course dates The International School of Thyroid Ultrasonography Advanced practical thyroid
More informationInternational School of Ultrasound in Obstetrics and Gynecology Paolo Mascagni Workshop on: Early evaluation of fetal echocardiography
SCIENTIFIC PROGRAMME International School of Ultrasound in Obstetrics and Gynecology Paolo Mascagni Workshop on: Early evaluation of fetal echocardiography 17-18 April 2015 - Siena, Italy Dear participant,
More informationRobert Fischer Fertility Centre Hamburg Hamburg, Germany
EXCEMED Blended Education Improving success in ART: how to define it and key strategies to get the best outcomes Live intervention in Beijing, China PRELIMINARY PROGRAMME Improving success in ART: how
More information14 October University of Namibia - Windhoek, Namibia
PROGRAMA CIENTÍFICO 2015 CME Africa Tour Clinical Chronic Diseases Management - Diabetes and Hypertension 14 October 2015 - University of Namibia - Windhoek, Namibia 2015 CME Africa Tour Clinical Chronic
More informationNeurology and Neurometabolic Unit Department of Neurological and Behavioral Sciences University of Siena Siena, Italy
Nicola De Stefano Neurology and Neurometabolic Unit Department of Neurological and Behavioral Sciences University of Siena Siena, Italy Declared receipt of honoraria or consultation fees from Novartis,
More informationCME Tour on clinical diabetes management PRELIMINARY PROGRAM
PRELIMINARY PROGRAM CME Tour on clinical diabetes management 28 October, 2013 - Kampala, Uganda 30 October, 2013 - Nairobi, Kenya 1 November, 2013 - Windhoek, Namibia CME Tour on clinical diabetes management
More information17-18 October Dubai, UAE
PRELIMINARY PROGRAMME Evidence based medicine in metastatic colorectal cancer workshop 17-18 October 2014 - Dubai, UAE Dear participant, A warm welcome to all attending the Evidence based medicine in metastatic
More informationInternational medical oncologists, surgeons and radiation oncologists experienced in the management of head and neck cancer patients.
Aim of the educational preceptorship Treatment options for patients with unresectable head and neck cancer have been significantly expanded over the last few years. Combined modality treatment with concomitant
More information24 October 2017 Paris, France
INTERNATIONAL COURSE PRELIMINARY PROGRAMME MS Academia: Multiple sclerosis advanced course 24 October 2017 Paris, France MS Academia - Multiple sclerosis advanced course Overview The complex world of multiple
More informationHo Huynh Quang Tri Heart Institute
EXCEMED Blended Education Cardiometabolic disorders in clinical practice: a comprehensive update Live intervention in PRELIMINARY PROGRAMME Cardiometabolic disorders in clinical practice: a comprehensive
More informationDear Participants, Yours sincerely, Silvia Cristofanelli EXCEMED
EXCEMED Blended Education 16 th practice teaching course in MS knowledge Live intervention in 12-13 November 2018 Dear Participants, On behalf of EXCEMED, it is our pleasure to welcome you to the live
More information30-31 October Milan, Italy
PRELIMINARY PROGRAMME Preceptorship on MRI in multiple sclerosis 30-31 October 2014 - Dear delegate, A warm welcome to all attending the course on: Preceptorship on MRI in multiple sclerosis. I would like
More informationPRELIMINARY PROGRAMME. 2nd European-Middle East Forum on Managing cardiovascular risk factors in clinical practice 6 December, Istanbul, Turkey
PRELIMINARY PROGRAMME 2nd European-Middle East Forum on Managing cardiovascular risk factors in clinical practice 6 December, 2013 - Istanbul, Turkey Background and aims of the conference Cardiovascular
More informationREGIONAL WORKSHOP FINAL PROGRAMME. Ovarian stimulation strategies: Nurturing efficiency in ART. 9 December Dubai, United Arab Emirates
REGIONAL WORKSHOP FINAL PROGRAMME Ovarian stimulation strategies: Nurturing efficiency in ART 9 December 2017 - Dubai, United Arab Emirates GENERAL INFO 2 3 GENERAL INFORMATION Ovarian stimulation strategies:
More informationregional conference final programme and Abstract book 16 November, Buenos Aires, Argentina
regional conference final programme and Abstract book 2016 Pre-LACTRIMS Conference 16 November, 2016 - Buenos Aires, Argentina 1 2016 Pre-LACTRIMS Conference Overview Multiple Sclerosis (MS) is the most
More informationregional workshop Multiple sclerosis management: the value of experience a Pre-MENACTRIMS workshop 23 November Dubai, UAE
regional workshop FINAL programme Multiple sclerosis management: the value of experience a Pre-MENACTRIMS workshop 23 November 2017 - Dubai, UAE General info 2 general information 3 Multiple Sclerosis
More informationClinical and research application of MRI in diagnosis and monitoring of multiple sclerosis
24-25 February 2016 - Siena, Italy Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org How
More information4-6 October Buenos Aires, Argentina
PRACTICE TEACHING COURSE FINAL PROGRAMME Practice teaching course in head and neck cancer management 4-6 October 2017 - Buenos Aires, Argentina GENERAL INFORMATION GENERAL INFO Practice teaching course
More informationPeriventricular T2-hyperintense lesions: does the number matter in CIS?
Periventricular T2-hyperintense lesions: does the number matter in CIS? Dott.ssa Caterina Lapucci Department of Neuroscience, Rehabilitation, Ophthalmology. Genetics, Maternal and Child Health (DINOGMI)
More informationMULTIPLE SCLEROSIS IN Managing the complexity of multiple sclerosis. Olga Ciccarelli and Alan Thompson
MULTIPLE SCLEROSIS IN 2015 Managing the complexity of multiple sclerosis Olga Ciccarelli and Alan Thompson The application of imaging biomarkers has provided new insights into the mechanisms of damage
More informationFINAL PROGRAMME AND ABSTRACT BOOK
FINAL PROGRAMME AND ABSTRACT BOOK General information Venue Melià Castilla Hotel Calle del Capitán Haya, 43 28020 Madrid, Spain Language Format Dedicated website The official language of this live educational
More information12-13 February Milan, Italy
FINAL PROGRAMME AND ABSTRACT BOOK Preceptorship on MRI in multiple sclerosis 12-13 February 2015 - Milan, Italy Dear participant, A warm welcome to all attending the course Preceptorship on MRI in multiple
More informationClinical and research application of MRI in diagnosis and monitoring of multiple sclerosis
24-25 February 2016 - Siena, Italy Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org What
More informationTony Traboulsee, MD Associate Professor (Medicine/Neurology) Head, UBC MS and NMO Programs. MRI Diagnostic Red Flags
Tony Traboulsee, MD Associate Professor (Medicine/Neurology) Head, UBC MS and NMO Programs MRI Diagnostic Red Flags UBC MS and NMO Research Programs LEARNING OBJECTIVES By the end of this presentation,
More informationTarget audience. Accreditation
Aim of the conference Cardiovascular diseases are the main cause of morbidities and mortality world wide, and related risk factors are particularly increasing. Hypertension and its complications, such
More informationMRI in Differential Diagnosis. CMSC, June 2, Jill Conway, MD, MA, MSCE
MRI in Differential Diagnosis CMSC, June 2, 2016 Jill Conway, MD, MA, MSCE Director, Carolinas MS Center Clerkship Director, UNCSOM-Charlotte Campus Charlotte, NC Disclosures Speaking, consulting, and/or
More informationPELVIC MRI COURSE. November 12-14, 2016
Memorial Sloan Kettering Cancer Center is pleased to announce: PELVIC MRI COURSE November 12-14, 2016 Conference Location: Memorial Sloan Kettering Cancer Center Rockefeller Research Laboratories 430 East
More information1st North American Workshop on Neuropathology and Epilepsy Surgery
April 27-30, 2017 Tudor Arms DoubleTree Hotel Cleveland, OH Endorsed by April 27-30, 2017 Tudor Arms DoubleTree Hotel Cleveland, OH Workshop Description Reliable neuropathological work-up of epilepsy-associated
More informationActualização no diagnóstico e tratamento das doenças desmielinizantes na infância. Silvia Tenembaum
Actualização no diagnóstico e tratamento das doenças desmielinizantes na infância Silvia Tenembaum Acquired CNS inflammatory/demyelinating disorders: Background information More frequent in children than
More informationMORNING COFFEE
Final on-site schedule for 5. October MICCAI 2015 BrainLes: Brain-lesion workshop (BrainLes) Ischemic Stroke Lesion Segmentation Challenge (ISLES) Brain Tumor Image Segmentation Challenge (BRATS) MORNING
More information6-8 July Vancouver, Canada
FINAL PROGRAMME Preceptorship on Advances in Multiple Sclerosis (MS) and Neuro-Myelitis Optica (NMO) 6-8 July 2015 - Vancouver, Canada General information Venue This live educational course takes place
More information8-13 March 2014 Ermatingen (Lake Constance), Switzerland
REPORT 13 th ESO-ESMO MASTERCLASS IN CLINICAL ONCOLOGY Chairs: N. Pavlidis, GR - R. A. Stahel, CH Scientific Coordinators: W. Gatzemeier, IT - R. Popescu, CH Course coordination / Management: F. Marangoni,
More informationVII EULAR Scientifically Endorsed Course on. Pisa, Italy May 3rd - 8th, Course Chairmen Stefano Bombardieri, Marta Mosca
VII EULAR Scientifically Endorsed Course on Pisa, Italy May 3rd - 8th, 2015 Course Chairmen Stefano Bombardieri, Marta Mosca Scientific Secretariat: Chiara Tani Organizing Secretariat: Luisa Marconcini,
More informationPELVIC MRI COURSE. November 12-14, 2016
Memorial Sloan Kettering Cancer Center is pleased to announce: PELVIC MRI COURSE November 12-14, 2016 Conference Location: Memorial Sloan Kettering Cancer Center Rockefeller Research Laboratories 430 East
More information13 th Congress of the European Hip Society
13 th Congress of the European Hip Society Congress President: Dr. Berend Willem Schreurs, Nijmegen CALL FOR ABSTRACTS 20 22 September 2018 The Hague, The Netherlands www.ehs-congress.org 13 th Congress
More informationTOBACCO DEPENDENCE IN CANCER CARE
ASSESSMENT & TREATMENT OF TOBACCO DEPENDENCE IN CANCER CARE Co-sponsored by the MSK Psycho-Oncology Education & Training Institute (POETI) ASSESSMENT AND TREATMENT OF TOBACCO DEPENDENCE IN CANCER CARE
More informationVasculitis Update 2017
June 24, 2017 Chicago, Illinois Sponsored by: Office of Continuing Medical Education Division of Rheumatology Vasculitis Clinical Research Consortium Vasculitis Foundation Page 2 About At Northwestern
More informationSESPRS 2016 ATLANTA OCULOPLASTIC SYMPOSIUM
9TH ANNUAL SESPRS 2016 ATLANTA OCULOPLASTIC SYMPOSIUM Video Surgical Panels: Experience vs Technique JANUARY 21, 2016 THE INTERCONTINENTAL HOTEL ATLANTA, GA 2016 ATLANTA OCULOPLASTIC SYMPOSIUM SCIENTIFIC
More informationPULMONARY HYPERTENSION. by CLINICAL CASES. Archiginnasio Palace
Under the Aegis of European Board for Accreditation in Cardiology PULMONARY HYPERTENSION by CLINICAL CASES An educational event of the University of Bologna Master Degree in Pulmonary Vascular Diseases
More informationBRAIN AND SPINE. A comprehensive update on neurological and neurosurgical topics for the primary care physician. Friday, May 15, 2009
A comprehensive update on neurological and neurosurgical topics for the primary care physician BRAIN AND SPINE 2009 Friday, May 15, 2009 Weill Cornell Medical College Uris Auditorium New York, NY REGISTER
More informationPRELIMINARY PROGRAMME
0 PRELIMINARY PROGRAMME OVERVIEW The aim of the symposium is to provide quality education, based on practical clinical experience, on all aspects of the nurse s role related to the management of thyroid
More informationRECTAL MRI WORKSHOP. One Workstation Per Participant - Space is limited! Includes Complimentary Registration to the Colorectal Centennial Symposium
RECTAL MRI WORKSHOP THURSDAY, NOVEMBER 9, 2017 Zuckerman Research Center, New York City One Workstation Per Participant - Space is limited! Includes Complimentary Registration to the Colorectal Centennial
More informationMaking the Connection Between Patients and Providers
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, April 27, 2019 Hawaii Convention Center
More information13-14 October Athens, Greece
INTERNATIONAL WORKSHOP FINAL PROGRAMME From poor response to low prognosis concept: The new POSEIDON criteria 13-14 October 2017 - Athens, Greece GENERAL INFORMATION GENERAL INFO From poor response to
More informationMS Academia: Multiple sclerosis advanced course
6 October 2015 - Barcelona, Spain MS Academia: Multiple sclerosis advanced course IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org Mark S. Freedman University of Ottawa and the Ottawa
More information737 NORTH MICHIGAN AVE. S U I T E CHICAGO, IL
737 NORTH MICHIGAN AVE. S U I T E 2 1 0 0 CHICAGO, IL 60611-5405 AACS PRESENTS L IVE SURGERY WORKSHOPS Complementary Facial Fat Grafting and Purse String Facelifting (LIMITED ENROLLMENT) September 28 29,
More informationPrimary Care Workshop Agenda
Alzheimer s Tennessee, Inc. Presents Strategies for Managing in Primary Care A Primary Care Workshop of The 26 th Annual Alzheimer s Disease Symposium December 9, 2011 Jubilee Banquet Center 6700 Jubilee
More informationTargeting the High-Risk Patient
This programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s). Each participant should claim only those hours of credit that have actually
More informationECTRIMS-MAGNIMS MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS FELLOWS Awardees
ECTRIMS-MAGNIMS MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS FELLOWS 2017 Awardees Soheil Damangir, PhD Optimizing crowd-sourced solutions toward generating large reference datasets for WM lesion segmentation
More informationECTRIMS-MAGNIMS MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS FELLOWS Awardees
ECTRIMS-MAGNIMS MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS FELLOWS 2018 Awardees Alberto Calvi, PhD Slowly Evolving Lesions (SELs) in multiple sclerosis Queen Square Multiple Sclerosis Centre, University
More informationCHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island
#CHAIR2014 7TH ANNUAL CHAIR SUMMIT Master Class for Neuroscience Professional Development September 11 13, 2014 Westin Tampa Harbour Island Sponsored by #CHAIR2014 Use of MRI in Clinical Decision- Making
More informationMaking the Connection
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, May 5, 2018 Hawaii Convention Center
More informationSATURDAY FEBRUARY 23, 2013
MAKING THE CONNECTION 8th 7th Year in a Unique National Series Improving Clinical Care and Adherence for Patients with Diabetes SATURDAY FEBRUARY 23, 2013 Tucson Convention Center Tucson, Arizona Continuing
More informationMaking the Connection
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, February 3, 2018 William A. Egan Civic
More informationCurrent Techniques in the Treatment of Severe Endometriosis
in the Treatment of Severe Endometriosis September 5 th to 7 th, 2011 Director: A. Wattiez France Faculty: J. Alcocer Mexico S. Barata Portugal M. Canis France J. Dequesne Switzerland H. Ferreira Portugal
More informationVisualisation of cortical MS lesions with MRI need not be further improved: Yes
Controversies in Multiple Sclerosis Visualisation of cortical MS lesions with MRI need not be further improved: Yes Jeroen J.G. Geurts [1] & Declan T. Chard [2] 1. Dept. of Anatomy & Neurosciences, VUmc
More informationSBRT IN THE MANAGEMENT OF PROSTATE CANCER SATELLITE SYMPOSIUM AT THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) 2018 ANNUAL MEETING ADVANCES IN
DEPARTMENT OF RADIATION ONCOLOGY ADVANCES IN SBRT IN THE MANAGEMENT OF PROSTATE CANCER SATELLITE SYMPOSIUM AT THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) 2018 ANNUAL MEETING OCTOBER 21, 2018 MARRIOTT
More informationMaking the Connection
Making the Connection Between Patients and Providers A Comprehensive Overview of the Modern Treatment Strategies For People With Type 1 and Type 2 Diabetes Saturday, March 17, 2018 Monterey Conference
More informationTh1/Th17 Cytokine Dysregulation during Different Stages of Multiple Sclerosis
Th1/Th17 Cytokine Dysregulation during Different Stages of Multiple Sclerosis Benjamin M. Segal, M.D. Holtom-Garrett Professor of Neurology Director, Multiple Sclerosis Program University of Michigan Disclosures
More informationTHC:CBD Daily Practice Evidence in MS Spasticity Management: The Moment of Large Databases
THC:CBD Daily Practice Evidence in MS Spasticity Management: The Moment of Large Databases Almirall-Sponsored Satellite Symposium of the 31 st Congress of the European Committee for Treatment and Research
More informationLink and Lead A look in the future and the role of transplant coordinators.
TRANSPLANTATION LEARNING JOURNEY Munich, Germany 6-10 2018 Second announcement 6-7 10 th ELITA 6-7 VCA 7 3 rd ETAHP 7-8 27 th 27 th Congress 3 rd Congress & Workshops Workshops 8 9-10 3 rd 9-10 Link and
More informationPer Soelberg Sørensen
Per Soelberg Sørensen Danish Multiple Sclerosis Center Department of Neurology Rigshospitalet, University of Copenhagen Copenhagen, Denmark Declared receipt personal compensation for serving on scientific
More informationSymposia on Mild Cognitive Impairment
*Artwork by permission of Memories in the Making art program. Indiana alzheimer Disease center Friday, April 18 and Saturday, April 19, 2008 Indiana Historical Society 450 West Ohio Street Indianapolis,
More informationHot Topics Multiple Sclerosis. Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018
Hot Topics Multiple Sclerosis Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018 Disclosures Natalie Parks has received compensation from Biogen, EMD Serono, Roche, and Sanofi
More informationHoa Van Le, MD, PhD (Presenter) PAREXEL International ISPOR 22nd Annual International Meeting, Boston, MA. May 23, 2017
Lessons Learned in Identifying Relapsing- Remitting Multiple Sclerosis in US Integrated Delivery Network Health Care Claims and Electronic Health Record Data Hoa Van Le, MD, PhD (Presenter) PAREXEL International
More informationPROGRAM SYLLABUS. Jointly provided by Potomac Center for Medical Education and Rockpointe
PROGRAM SYLLABUS Jointly provided by Potomac Center for Medical Education and Rockpointe This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding
More informationHeterogeneity of Demyelinating Disease: Definitions and Overlap Overview
Heterogeneity of Demyelinating Disease: Definitions and Overlap Overview Brian Weinshenker, MD, FRCP(C) Disclosures Royalties related to patent for discovery of NMO-IgG licensed to RSR Ltd; Oxford University
More informationMayo Clinic Rochester, MN PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AWARD NUMBER: W81XWH-13-1-0098 TITLE: Cortical Lesions as Determinants of White Matter Lesion Formation and Cognitive Abnormalities in MS PRINCIPAL INVESTIGATOR: John D. Port, M.D., Ph.D. CONTRACTING ORGANIZATION:
More informationMRI and differential diagnosis in patients suspected of having MS
Andrea Falini Italy MRI and differential diagnosis in patients suspected of having MS IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org Outline of presentation - Diagnostic criteria
More informationUltrasound Guided Vascular Access March 22, 2018
Thursday, Ultrasound Guided 7:45 Welcome and Continental Breakfast 8:00 Interactive Polling Session 8:15 Ultrasound Imaging Fundamentals Lori Green, BA, RT(R), RDMS, RDCS, RVT 9:00 Break 9:15 The Fundamentals
More informationMRI in MS: the radiologist perspective
MS Preceptorship - Updating Knowledge in Multiple Sclerosis - June, 1-3 2010 Barcelona MRI in MS: the radiologist perspective Àlex Rovira Unidad de Resonancia Magnética Servicio de Radiología Hospital
More informationLIVER CANCER: MANAGEMENT AND CHALLENGES
The LIVER CANCER: MANAGEMENT AND CHALLENGES Hatch Auditorium Guggenheim Pavilion, 2nd Floor 1468 Madison Ave. at 100th St., New York, NY Program Director: Josep M. Llovet, MD Professor of Medicine Director,
More informationOSTEOPOROSIS ESSENTIALS: DENSITOMETRY, DIAGNOSIS & MANAGEMENT
OSTEOPOROSIS ESSENTIALS: DENSITOMETRY, DIAGNOSIS & MANAGEMENT CME credits An IOF-ISCD Course Offered by OSTEOS Program November 25-26, 2015 Gefinor Rotana Hotel - Beirut, Lebanon Clinician Track The Clinician
More informationStanford Breast in the West: Multi-Modality Breast Imaging Symposium for Radiologists
Course Overview Stanford Breast in the West: Multi-Modality Breast Imaging Symposium for Radiologists October 18-20, 2018 Monterey Plaza Hotel Monterey, CA A Continuing Medical Education Conference presented
More informationHelpful Information for evaluation of new neurological symptoms in patients receiving TYSABRI
Helpful Information for evaluation of new neurological symptoms in patients receiving TYSABRI This information is provided as an educational resource for healthcare providers and should be considered current
More informationHispanic Women s Heart Health Today:
Hispanic Women s Heart Health Today: Applying the Guidelines Toward Hispanic Heart Healthy Initiatives Saturday, October 6, 2012 Montefiore Moses Campus Tishman Learning Center 111 East 210th Street Bronx,
More informationLife Long Brain Health and DMT Comparative Effectiveness
Life Long Brain Health and DMT Comparative Effectiveness Timothy Vollmer, MD Professor of Neurology University of Colorado Denver Medical Director- RMMSC and Co-Director Rocky Mountain MS Center at CU
More informationINTERNATIONAL MASTERCLASS ON LIVER DISEASE IN HIV VILNIUS, LITHUANIA 18 SEPTEMBER 2019 (TBC) REQUEST FOR SUPPORT.
INTERNATIONAL MASTERCLASS ON LIVER DISEASE IN HIV VILNIUS, LITHUANIA 18 SEPTEMBER 2019 (TBC) REQUEST FOR SUPPORT INTRODUCTION Liver disease in the setting of HIV is increasingly presenting a major concern
More informationFriday, April 22, 2016 NRB Auditorium UCLA Campus Los Angeles, California
Advances in Autism 2016 Friday, April 22, 2016 NRB Auditorium UCLA Campus Los Angeles, California Course Description This full-day symposium is for physicians, psychiatrists, psychologists, health professionals,
More informationNew Insights on Optic Neuritis in Young People
Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Study New Insights on Optic Neuritis in Young People Sergio Carmona 1, Sandra Barbosa 1 and Maria Laura Ortube 2 * 1 Department of Neuro-ophthalmology, Hospital
More information2016 INTENSIVE BREAST ULTRASOUND
New lectures based on new classification of breast disease 2016 INTENSIVE BREAST ULTRASOUND A Histopathologically based Approach to Diagnostic and Screening Breast Ultrasound SEPTEMBER 15-18, 2016 THE
More informationAccommodations. Neurosurgeons, Spine Surgeons. Spine and Neurosurgery clinicians. Spine and Neurosurgery Residents and Fellows.
This symposium is designed for practicing physicians in Neurosurgery, Neurology, Spine Surgery, nurses/physician assistants who are interested in the most recent treatment options, emerging therapies and
More information